Neurology
News
Type 2 diabetes may promote Parkinson development
Individuals with type 2 diabetes may be at increased risk of Parkinson’s disease in later life, particularly those who develop diabetes at a...
Article
Neurology Board Review: Multiple Sclerosis
FDA/CDC
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
Article
Parkinson’s disease: A treatment guide
By following this stepwise approach, you can confidently incorporate newer agents into your armamentarium with little or no consultation with...
Conference Coverage
Common infections are potent risk factor for MI, stroke
ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.
Conference Coverage
Guidelines May Help Reduce Stroke Risk in Patients With Diabetes
LOS ANGELES—Current guidelines can help physicians prevent stroke in patients with diabetes, according to a lecture delivered at the International...
Latest News
FDA advisors recommend lofexidine for opioid withdrawal
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
Conference Coverage
EMS stroke field triage improves outcomes
EMS transfer of large-vessel stroke patients to a comprehensive stroke center led to quicker treatment, even when a primary stroke center was...